Fenfluramine/phentermine
FDA panel recommends approval of anti-obesity drug
An advisory panel of outside physicians for the FDA recommended approval of the weight-loss drug Qnexa, which was previously rejected in 2010. Pending approval, Qnexa could be the most effective non-surgery treatment for obese people. The FDA will make a final decision later this year.